C. Dervenis

1.8k total citations · 1 hit paper
11 papers, 1.2k citations indexed

About

C. Dervenis is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, C. Dervenis has authored 11 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Surgery and 3 papers in Epidemiology. Recurrent topics in C. Dervenis's work include Pancreatic and Hepatic Oncology Research (8 papers), Pancreatitis Pathology and Treatment (6 papers) and Neuroendocrine Tumor Research Advances (2 papers). C. Dervenis is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Pancreatitis Pathology and Treatment (6 papers) and Neuroendocrine Tumor Research Advances (2 papers). C. Dervenis collaborates with scholars based in Greece, Italy and Germany. C. Dervenis's co-authors include C. Bassi, John P. Neoptolemos, E. L. Bradley, C W Imrie, Irvin M. Modlin, Michael McMahon, H. G. Beger, Janet Dunn, Laureano Fernández‐Cruz and P. Pederzoli and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

C. Dervenis

10 papers receiving 1.1k citations

Hit Papers

Adjuvant chemoradiotherapy and chemotherapy in resectable... 2001 2026 2009 2017 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Dervenis Greece 6 1.0k 686 384 351 226 11 1.2k
N. Alexakis Greece 23 1.1k 1.1× 1.3k 2.0× 695 1.8× 317 0.9× 62 0.3× 55 1.8k
Jong-Chan Lee South Korea 18 539 0.5× 311 0.5× 271 0.7× 167 0.5× 127 0.6× 77 854
K.K. Madhavan United Kingdom 12 516 0.5× 711 1.0× 305 0.8× 128 0.4× 48 0.2× 18 911
Masatoshi Isogai Japan 18 463 0.5× 759 1.1× 445 1.2× 278 0.8× 86 0.4× 109 1.2k
Paul Glen United Kingdom 9 508 0.5× 323 0.5× 154 0.4× 147 0.4× 123 0.5× 26 734
Elena Rangelova Sweden 17 1.0k 1.0× 488 0.7× 351 0.9× 187 0.5× 156 0.7× 42 1.2k
Mladjan Protić Serbia 16 762 0.8× 623 0.9× 291 0.8× 99 0.3× 136 0.6× 32 1.2k
Marco Bustamante Spain 17 484 0.5× 431 0.6× 406 1.1× 137 0.4× 64 0.3× 74 1.0k
Marianna Signoretti Italy 15 556 0.6× 549 0.8× 139 0.4× 153 0.4× 85 0.4× 24 827
Shilpa Grover United States 17 726 0.7× 235 0.3× 176 0.5× 158 0.5× 150 0.7× 60 1.1k

Countries citing papers authored by C. Dervenis

Since Specialization
Citations

This map shows the geographic impact of C. Dervenis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Dervenis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Dervenis more than expected).

Fields of papers citing papers by C. Dervenis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Dervenis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Dervenis. The network helps show where C. Dervenis may publish in the future.

Co-authorship network of co-authors of C. Dervenis

This figure shows the co-authorship network connecting the top 25 collaborators of C. Dervenis. A scholar is included among the top collaborators of C. Dervenis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Dervenis. C. Dervenis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bannone, Elisa, Giovanni Marchegiani, Roberto Salvia, et al.. (2023). Preliminary Results of the Clinical and Economic Validation of the ISGPS Definition of Postpancreatectomy AcutePancreatitis (PPAP). HPB. 25. S241–S241.
2.
Neoptolemos, John P., Malcolm J. Moore, Trevor F. Cox, et al.. (2011). Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater.. Journal of Clinical Oncology. 29(18_suppl). LBA4006–LBA4006. 14 indexed citations
5.
Andrén‐Sandberg, Åke & C. Dervenis. (2003). Surgical treatment of pancreatic pseudocysts in the 2000s: The laparoscopic approach. Acta chirurgica iugoslavica. 50(4). 21–26. 5 indexed citations
6.
Falconi, Massimo, Claudio Bassi, C. Dervenis, et al.. (2002). Cystic tumours of the pancreas: a review.. PubMed. 53(5). 595–608. 1 indexed citations
7.
Neoptolemos, John P., Janet Dunn, Deborah Stocken, et al.. (2001). Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. The Lancet. 358(9293). 1576–1585. 773 indexed citations breakdown →
8.
Neoptolemos, John P., Janet Dunn, Jennifer Almond, et al.. (2001). European Study Group for Pancreatic Cancer-1 interim results: a European randomized study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer. British journal of surgery. 88(3). 475–475. 5 indexed citations
9.
Dervenis, C., C. Bassi, E. L. Bradley, et al.. (1999). Diagnosis, objective assessment of severity, and management of acute pancreatitis. International Journal of Pancreatology. 25(3). 195–210. 336 indexed citations
10.
Bassi, Claudio, Massimo Falconi, G. Talamini, et al.. (1998). Results of a multicenter clinical trial of pefloxacin versus imipenem in severe pancreatitis. Gastroenterology. 114. A1378–A1378. 1 indexed citations
11.
Vagianos, C., et al.. (1995). Bacterial Translocation and Endotoxemia in Obstructive Jaundice: The Protective Effect of Lactulose. Digestive Surgery. 12(6). 321–326. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026